Literature DB >> 64697

Stress deficiency of the T-lymphocyte system exemplified by Down syndrome.

S Whittingham, D B Pitt, D L Sharma, I R Mackay.   

Abstract

A comparison of immune competence in 26 patients with Down syndrome in an institution and 26 matched healthy controls revealed an atypical pattern of T-cell immunodeficiency in the Down-syndrome patients. The patients with Down syndrome had a lymphocytosis in blood with high counts of T (and B) cells, but with impaired effector function of T cells as judged by anergy to dinitrochlorobenzene, low responsiveness to ubiquitous antigens which elicit delayed-type hypersensitivity reactions, and low mitogenic activity of non-stimulated and phytohaemagglutinin-stimulated lymphocytes in culture. Helper-T-cell function measured by the humoral immune response to flagellin was intact, and there were minor abnormalities of the B-cell system. Attempted restoration of T-cell function with levamisole was unsuccessful. This pattern of T-lymphocytosis with impaired effector function could be explained by "stress-deficiency" of the immune system consequent upon a heavy load of infection in early life.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 64697     DOI: 10.1016/s0140-6736(77)91763-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

2.  T cell response to anti-CD3 antibody in Down's syndrome.

Authors:  A Bertotto; C Arcangeli; S Crupi; I Marinelli; R Gerli; R Vaccaro
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

3.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

4.  Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.

Authors:  R Maccario; A G Ugazio; L Nespoli; C Alberini; D Montagna; F Porta; F Bonetti; G R Burgio
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.

Authors:  S Gupta; S M Fikrig; E Mariano; Q Quazi
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

6.  Graves' disease and Down's syndrome.

Authors:  A J McCulloch; F Clark; N R Steele
Journal:  J Med Genet       Date:  1983-04       Impact factor: 6.318

7.  Autoimmune chronic active hepatitis in Down's syndrome.

Authors:  A J McCulloch; P G Ince; P Kendall-Taylor
Journal:  J Med Genet       Date:  1982-06       Impact factor: 6.318

8.  NK and K cell activity of human blood: differences according to sex, age, and disease.

Authors:  J Penschow; I R Mackay
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

9.  Cloning of T-lymphocytes in systemic lupus erythematosus.

Authors:  S Whittingham; B Rodger; J V Matthews; I R Mackay
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

10.  Immunological and virological investigations in Down's syndrome.

Authors:  G Fekete; G Kulcsár; P Dán; I Nász; D Schuler; M Dobos
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.